biostudies-literatureUnknown41(4)Diana P<h4>Purpose</h4>To systematically review studies focused on screening programs for renal cell carcinoma (RCC) and provide an exhaustive overview on their clinical impact, potential benefits, and harms.<h4>Methods</h4>A systematic review of the recent English-language literature was conducted according to the European Association of Urology guidelines and the PRISMA statement recommendations (PROSPERO ID: CRD42021283136) using the MEDLINE, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases. Risk-of-bias assessment was performed according to the QUality In Prognosis Studies (QUIPS) tool.<h4>Results</h4>Overall, nine studies and one clinical trials were included. Eight studies reported results from RCC screening programs involving a total of 159 136 patients and World journal of urology929-940https://www.ebi.ac.uk/biostudies/studies/S-EPMC10160199biostudies-literatureScreening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.PMC10160199Diana PKlatte TMarchioni MIngels APavan NCampi RCarbonara UMarandino LRoussel EMuselaers SAmparore DEuropean Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer groupKara OErdem SBertolo RPecoraro AfalseScreening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.<h4>Purpose</h4>To systematically review studies focused on screening programs for renal cell carcinoma (RCC) and provide an exhaustive overview on their clinical impact, potential benefits, and harms.<h4>Methods</h4>A systematic review of the recent English-language literature was conducted according to the European Association of Urology guidelines and the PRISMA statement recommendations (PROSPERO ID: CRD42021283136) using the MEDLINE, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases. Risk-of-bias assessment was performed according to the QUality In Prognosis Studies (QUIPS) tool.<h4>Results</h4>Overall, nine studies and one clinical trials were included. Eight studies reported results from RCC screening programs involving a total of 159 136 patients and 2023-01-01T00:00:00Z2023 Apr2026-05-02T11:15:00.378Z2025-02-19T04:29:04.57ZS-EPMC101601993536274710.1007/s00345-022-03993-6